Brokerages forecast that Cerner Co. (NASDAQ:CERN) will report sales of $1.33 billion for the current fiscal quarter, Zacks Investment Research reports. Eleven analysts have provided estimates for Cerner’s earnings. The lowest sales estimate is $1.31 billion and the highest is $1.35 billion. Cerner posted sales of $1.26 billion in the same quarter last year, which suggests a positive year over year growth rate of 5.6%. The firm is expected to report its next quarterly earnings results after the market closes on Tuesday, February 6th.

On average, analysts expect that Cerner will report full year sales of $1.33 billion for the current year, with estimates ranging from $5.14 billion to $5.18 billion. For the next fiscal year, analysts forecast that the business will report sales of $5.59 billion per share, with estimates ranging from $5.51 billion to $5.65 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover Cerner.

Cerner (NASDAQ:CERN) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.62 by ($0.01). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the firm posted $0.59 EPS.

CERN has been the topic of a number of research analyst reports. Zacks Investment Research lowered shares of Cerner from a “hold” rating to a “sell” rating in a research note on Tuesday, September 26th. Cantor Fitzgerald reiterated a “buy” rating and set a $77.00 price objective on shares of Cerner in a research note on Tuesday, October 10th. Piper Jaffray Companies reiterated a “buy” rating and set a $77.00 price objective on shares of Cerner in a research note on Thursday, October 12th. Jefferies Group set a $79.00 price objective on shares of Cerner and gave the company a “buy” rating in a research note on Friday, October 13th. Finally, SunTrust Banks reiterated a “buy” rating and set a $79.00 price objective on shares of Cerner in a research note on Thursday, October 19th. Seventeen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $70.21.

Cerner (CERN) traded down $0.58 during midday trading on Monday, hitting $68.91. 3,157,800 shares of the company were exchanged, compared to its average volume of 1,811,054. Cerner has a fifty-two week low of $50.33 and a fifty-two week high of $73.86. The company has a quick ratio of 2.75, a current ratio of 2.77 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $22,940.00, a price-to-earnings ratio of 34.28, a PEG ratio of 2.05 and a beta of 0.94.

In related news, VP Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total value of $279,560.00. Following the completion of the transaction, the vice president now owns 4,000 shares of the company’s stock, valued at approximately $279,560. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Marc G. Naughton sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $70.64, for a total transaction of $4,238,400.00. The disclosure for this sale can be found here. Insiders sold a total of 788,000 shares of company stock valued at $52,190,800 in the last ninety days. Company insiders own 13.11% of the company’s stock.

Several large investors have recently modified their holdings of CERN. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Cerner during the 2nd quarter valued at $44,524,000. Sawgrass Asset Management LLC acquired a new stake in shares of Cerner during the 3rd quarter valued at $39,946,000. Koch Industries Inc. acquired a new stake in shares of Cerner during the 2nd quarter valued at $310,000. Commonwealth Bank of Australia boosted its stake in shares of Cerner by 1,362.5% during the 3rd quarter. Commonwealth Bank of Australia now owns 261,011 shares of the company’s stock valued at $18,389,000 after buying an additional 243,164 shares during the period. Finally, Russell Investments Group Ltd. boosted its stake in shares of Cerner by 18.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,213,944 shares of the company’s stock valued at $86,568,000 after buying an additional 185,957 shares during the period. 81.85% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Analysts Expect Cerner Co. (CERN) Will Announce Quarterly Sales of $1.33 Billion” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2018/01/22/analysts-expect-cerner-co-cern-will-announce-quarterly-sales-of-1-33-billion.html.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Get a free copy of the Zacks research report on Cerner (CERN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.